Trial intelligence / Profile preview

Tranexamic Acid in Pediatric Craniosynostosis Surgery

NCT02180321Completed

Sponsor
Yonsei University
Start
Jun 2013
Primary completion
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of tranexamic acid in Craniosynostosis (2 arms), sponsored by Yonsei University. Primary endpoint: Bleeding loss at 48 hours. Started Jun 2013; status: completed.

02

Drugs

tranexamic acid
03

Conditions

Craniosynostosis

Beyond the preview

Go deeper on NCT02180321.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02180321.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call